Trademark: 79333465
Word
CORX
Status
Registered
Status Code
700
Status Date
Tuesday, June 27, 2023
Serial Number
79333465
Registration Number
7088890
Registration Date
Tuesday, June 27, 2023
Mark Type
3000
Filing Date
Monday, October 25, 2021
Published for Opposition
Tuesday, April 11, 2023

Trademark Owner History
Cimplrx Co., Ltd. - Original Registrant

Classifications
9 Downloadable computer software for drug discovery; downloadable computer programs for drug discovery; downloadable computer software for diagnosing diseases for medical purposes; recorded computer software for drug discovery; recorded computer programs for drug discovery; recorded computer software for diagnosing diseases for medical purposes; downloadable data processing software; recorded data processing software; downloadable computer software to enable searching of data; recorded computer software to enable searching of data; downloadable database management software applications; downloadable computer software for creating searchable databases; recorded computer software for creating searchable databases; downloadable computer software for accessing information directories that may be downloaded from the global computer network; recorded computer software for accessing information directories that may be downloaded from the global computer network; downloadable computer software for use in providing multiple user access to a global computer information network; recorded computer software for use in providing multiple user access to a global computer information network; downloadable computer operating system software; recorded computer operating system software
42 New pharmaceutical research and development; drug discovery services; conducting early evaluations in the field of new pharmaceuticals; research relating to pharmaceuticals; pharmaceutical drug development services; pharmaceutical research and development; laboratory research in the field of pharmaceuticals; research and development of vaccines and medicines; medicine research; providing information on research and development of new products, namely, information on the testing, inspection, and research of medical products; scientific research in the field of pharmaceuticals; scientific research in the fields of biomedicine; development of computer software for drug discovery; development and creation of computer programmes for data processing; providing online non downloadable software for drug discovery; providing online non downloadable software for diagnosing diseases for medical purposes; providing online non downloadable software for processing, searching, and creating data; providing online non downloadable software for accessing information directories that may be downloaded from the global computer network; providing online non downloadable software for use in providing multiple user access to a global computer information network; rental of software for drug discovery; updating and adapting of computer programs according to user requirements; software as a service (SaaS) featuring software for drug discovery; software as a service (SaaS) featuring software for diagnosing diseases for medical purposes; software as a service (SaaS) featuring software for processing, searching, and creating data; software as a service (SaaS) featuring software for accessing information directories that may be downloaded from the global computer network; software as a service (SaaS) featuring software for use in providing multiple user access to a global computer information network; providing PaaS (platform as a service) featuring software for drug discovery; providing PaaS (platform as a service) featuring software for diagnosing diseases for medical purposes; providing PaaS (platform as a service) featuring software for processing, searching, and creating data; providing PaaS (platform as a service) featuring software for accessing information directories that may be downloaded from the global computer network; providing PaaS (platform as a service) featuring software for use in providing multiple user access to a global computer information network
The mark consists of the letters "C", "O", "R", and "X" contained in a box outlined in sky blue; the colors of the letter "O" is sky blue and the colors of the letters C, R, and X is black. The color white within the box is for background purposes only and is not claimed as a feature of the mark.
The color(s) sky blue and black is/are claimed as a feature of the mark.
"RX"

Trademark Events
Oct 24, 2023
Final Decision Transaction Processed By Ib
Sep 28, 2023
Final Disposition Notice Sent To Ib
Sep 28, 2023
Final Disposition Processed
Sep 27, 2023
Final Disposition Notice Created, To Be Sent To Ib
Jun 27, 2023
Notice Of Registration Confirmation Emailed
Jun 27, 2023
Registered-Principal Register
Apr 13, 2023
Notification Processed By Ib
Apr 11, 2023
Official Gazette Publication Confirmation E-Mailed
Apr 11, 2023
Published For Opposition
Mar 22, 2023
Notification Of Possible Opposition Sent To Ib
Mar 22, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 22, 2023
Notification Of Notice Of Publication E-Mailed
Mar 7, 2023
Approved For Pub - Principal Register
Mar 7, 2023
Examiner's Amendment Entered
Mar 7, 2023
Notification Of Examiners Amendment E-Mailed
Mar 7, 2023
Examiners Amendment E-Mailed
Mar 7, 2023
Examiners Amendment -Written
Feb 18, 2023
Teas/Email Correspondence Entered
Feb 17, 2023
Correspondence Received In Law Office
Feb 17, 2023
Teas Response To Office Action Received
Sep 6, 2022
Refusal Processed By Ib
Aug 17, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Aug 17, 2022
Refusal Processed By Mpu
Jul 27, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Jul 26, 2022
Non-Final Action Written
Jul 21, 2022
Assigned To Examiner
Mar 8, 2022
Application Filing Receipt Mailed
Mar 3, 2022
New Application Office Supplied Data Entered
Feb 17, 2022
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24